Baillie Gifford & Co’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-48,791
| Closed | -$89.8K | – | 282 |
|
|
2024
Q4 | $89.8K | Sell |
48,791
-1,470,550
| -97% | -$2.71M | ﹤0.01% | 258 |
|
|
2024
Q3 | $5.26M | Sell |
1,519,341
-329,410
| -18% | -$1.14M | ﹤0.01% | 230 |
|
|
2024
Q2 | $5.42M | Buy |
1,848,751
+1,845
| +0.1% | +$5.41K | ﹤0.01% | 234 |
|
|
2024
Q1 | $10.4M | Sell |
1,846,906
-19,944
| -1% | -$113K | 0.01% | 224 |
|
|
2023
Q4 | $8.01M | Sell |
1,866,850
-804
| -0% | -$3.45K | 0.01% | 230 |
|
|
2023
Q3 | $6.48M | Hold |
1,867,654
| – | – | 0.01% | 229 |
|
|
2023
Q2 | $8.68M | Hold |
1,867,654
| – | – | 0.01% | 224 |
|
|
2023
Q1 | $8.63M | Sell |
1,867,654
-961
| -0.1% | -$4.44K | 0.01% | 225 |
|
|
2022
Q4 | $15.1M | Hold |
1,868,615
| – | – | 0.02% | 198 |
|
|
2022
Q3 | $10.4M | Buy |
1,868,615
+3,435
| +0.2% | +$19.1K | 0.01% | 214 |
|
|
2022
Q2 | $9.72M | Sell |
1,865,180
-3,321
| -0.2% | -$17.3K | 0.01% | 216 |
|
|
2022
Q1 | $15.4M | Buy |
1,868,501
+13,251
| +0.7% | +$109K | 0.01% | 216 |
|
|
2021
Q4 | $27.6M | Buy |
1,855,250
+60,310
| +3% | +$897K | 0.02% | 208 |
|
|
2021
Q3 | $33.9M | Buy |
1,794,940
+767
| +0% | +$14.5K | 0.02% | 204 |
|
|
2021
Q2 | $33.4M | Buy |
1,794,173
+98,519
| +6% | +$1.83M | 0.02% | 209 |
|
|
2021
Q1 | $38.6M | Hold |
1,695,654
| – | – | 0.02% | 198 |
|
|
2020
Q4 | $36.8M | Hold |
1,695,654
| – | – | 0.02% | 177 |
|
|
2020
Q3 | $17M | Buy |
1,695,654
+195,654
| +13% | +$1.97M | 0.01% | 190 |
|
|
2020
Q2 | $11.6M | Buy |
+1,500,000
| New | +$11.6M | 0.01% | 189 |
|